We report novel aspects such as the early-onset schizencephaly, the CFTR carrier status with borderline sweat chloride test, and the presence of multiple allergic and behavioral comorbidities, which underscores the importance of early genetic evaluation. This evidence concerns the gene CFTR and schizencephaly.